Wade Nishimoto in El Segundo, California

Home California El Segundo

Wade Nishimoto has Hematology/oncology as his primary medical specialty. Their primary office is: 390 N Pacific Coast Hwy in El Segundo, California.

They're a part of the: California Hematology Oncology Medical Group medical group which has around 5 members. You can call their office at 310-649-7222 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of California, Irvine, California College Of Medicine and graduated in 1987 (around 37 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Wade Y Nishimoto Office Phone and Directions

Wade Nishimoto
California Hematology Oncology Medical Group
390 N Pacific Coast Hwy
El Segundo, California 90245
310-649-7222

Patient Ratings
Please rate your experience with Wade Nishimoto below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 310-649-7222

Enter a starting address:

Healthcare Info for Wade Nishimoto

Medical School: University Of California, Irvine, California College Of Medicine
Graduation Year: 1987
The Primary Medical Specialty for Wade Nishimoto is listed as: Hematology/oncology
Approximate Years of Experience: 37
PAC (PECOS ID)#: 5597881805
NPI #: 1083641518
NPI Created On: 06/28/2006
NPI Last Updated Listed as: 12/13/2007
Primary Taxonomy Code: 207RH0003X
License Number:
G56797
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Filipino (philipino), Chinese.

Services and Procedures include:

Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
Therapeutic removal of whole blood to correct blood level imbalance
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 5 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic
Injection, denosumab, 1 mg
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, ferric carboxymaltose, 1 mg
Injection, palonosetron hcl, 25 mcg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787673031

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013543

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013545

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013549

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013547

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818821703

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $33

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802114127

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832157403

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832157455

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832157480

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Hematology/oncology Professionals in El Segundo

1.
Frank Mori

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

2.
Alex Makalinao

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

3.
Leonard Sender MD

2040 E Mariposa Ave
El-segundo, CA
Immuno-oncology Clinic Inc.

4.
Mark Ngo MD

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

5.
Xiuqing Ru MD

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

Providers in California Hematology Oncology Medical Group

1.Alex Makalinao

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

2.Frank Mori

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

3.Mark Ngo Md

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

4.Wade Nishimoto

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

5.Xiuqing Ru Md

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

View all 5 members of California Hematology Oncology Medical Group medical group